Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced ...
For R&D leaders evaluating AI investments, I’d offer one piece of advice: Before spending more on models, look hard at your ...
SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...
Organoids and engineered systems are transforming malaria research, improving drug discovery and understanding of Plasmodium ...
U.S. academic medical centers risk losing leadership in drug discovery and development as global competition—especially from ...
The fourth edition reflects both the maturation of Generative AI and our deeper understanding of its practical application in discovery and investigations. Since the third edition, AI systems have ...
AI could "give the scientific community a way to address the most difficult and urgent questions in human health," argues .
The Electronic Discovery Reference Model (EDRM) is undergoing a remodel, as myriad data sources, growing ESI, and new technology is turning e-discovery into a non-linear, complex process. [Editor’s ...
The field of pharmacophore modeling has steadily emerged as a cornerstone in the rational design of kinase inhibitors. By abstracting the essential molecular features required for optimal binding to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results